Melanoma Insights for Professionals
Episodes
After the diagnosis: Getting follow-up care right in melanoma
02 Dec 2025
Contributed by Lukas
As patients transition from treatment to routine monitoring, clinicians play a crucial part in detecting recurrence early, supporting wellbeing, and g...
Overdiagnosis or early detection? The controversy of melanoma in situ
21 Oct 2025
Contributed by Lukas
As melanoma in situ (MIS) diagnoses rise, concerns about overdiagnosis are growing — with real implications for patients, clinicians and the health ...
Utilising melanoma risk prediction tools for newly diagnosed patients
15 Aug 2025
Contributed by Lukas
In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, de...
Sentinel node biopsy in melanoma: Still recommended in 2025?
20 Jun 2025
Contributed by Lukas
In this episode of Melanoma Insights for Professionals, we explore the evolving role of sentinel node biopsy (SNB) in melanoma management—particular...
Integrating AI in melanoma care
14 May 2025
Contributed by Lukas
In this episode of Melanoma Insights for Professionals, we explore the cutting-edge role of artificial intelligence (AI) in diagnosing melanoma.Join D...
The future of melanoma detection and management: Perspectives from world-leading clinicians
05 Nov 2024
Contributed by Lukas
In this special podcast recorded from the 2024 Australasian Melanoma Conference, we hear from our international keynote speakers, Prof Susan Swetter a...
Unveiling melanoma research: Shaping the future with innovative research infrastructure
02 Sep 2024
Contributed by Lukas
Comprehensive infrastructure is essential to driving research progress and improving patient care. In this podcast, A/Prof Sydney Ch’ng leads an in...
Transforming cancer care: Neoadjuvant therapy and trials in melanoma care
03 Jun 2024
Contributed by Lukas
Neoadjuvant immunotherapy is transforming patient care in the field of melanoma. New research recently presented at the American Society of Clinical O...
Current and emerging biomarkers for melanoma care
21 May 2024
Contributed by Lukas
Biomarkers are revolutionising our understanding of melanoma by providing valuable information about a patient's unique tumour characteristics which c...
Spotlight on mucosal melanoma: Head and neck
02 Apr 2024
Contributed by Lukas
Mucosal melanoma is a rare and aggressive form of melanoma that arises from the mucous membrane. In this podcast, we focus on mucosal melanoma of the ...
Dealing with diagnostic uncertainty and borderline pathology
29 Nov 2023
Contributed by Lukas
Diagnostic uncertainty in the context of cutaneous melanoma can have significant impact on patient care. In this podcast, our multidisciplinary expert...
Melanoma: When do I scan?
27 Sep 2023
Contributed by Lukas
With the advent of effective medical therapies for melanoma, a pertinent question has arisen: When should we scan our patients? In this podcast, our m...
When to recommend a sentinel node biopsy in melanoma
07 Jul 2023
Contributed by Lukas
Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas. In this fireside chat from our new SNB Training Program (Sentinel...
Neoadjuvant immunotherapy: Revolutionising melanoma treatment
13 Mar 2023
Contributed by Lukas
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy - administering checkpoint inhibitor immunotherapy before the s...
Unravelling lentigo maligna
06 Feb 2023
Contributed by Lukas
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshila...
Diagnosis and management of uveal melanoma
16 Nov 2022
Contributed by Lukas
Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcom...
Getting the pathology right: Melanoma in General Practice
31 Aug 2022
Contributed by Lukas
Treating clinicians rely on pathology to help diagnose and stage their patient which fundamentally determines the treatment management plan. Theref...
Critical questions for a melanoma pathologist
27 Jun 2022
Contributed by Lukas
The role of pathology in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the pathologi...
Toxicity management in melanoma
17 May 2022
Contributed by Lukas
Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of...
The evolving paradigm shift in melanoma
10 Feb 2022
Contributed by Lukas
The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient ou...
Multidisciplinary management of in-transit melanoma
27 Oct 2021
Contributed by Lukas
Managing in-transit melanoma can be challenging, and it presents and progresses as a heterogeneous disease. Multidisciplinary care is recommended for ...
Multidisciplinary management of primary melanoma
29 Jun 2021
Contributed by Lukas
Melanoma has many mimics, making detection a challenge. However, early detection and appropriate management of melanoma is crucial to ensuring a patie...
Multidisciplinary management of Merkel cell carcinoma
28 Apr 2021
Contributed by Lukas
Due to the highly aggressive nature of Merkel cell carcinoma, accurate and timely diagnosis is essential to ensure optimal management. Although our un...
Multidisciplinary management of SCC and BCC
30 Mar 2021
Contributed by Lukas
Hear our expert multidisciplinary panel discuss the latest management options for the treatment of squamous cell carcinoma and basal cell carcinoma - ...
The complexities of adjuvant therapy in melanoma
10 Feb 2021
Contributed by Lukas
The success of immunotherapy and targeted therapy in the treatment of advanced melanoma has led to the same therapies being used in the adjuvant setti...
Emerging therapies in advanced melanoma in 2020
29 Jun 2020
Contributed by Lukas
In the rapidly evolving treatment landscape for advanced melanoma, medical oncologists now have a suite of treatments to choose from for their patient...
Melanoma in children and adolescents
15 Mar 2020
Contributed by Lukas
Melanoma is one of the most common human malignancies, however we often don't often think of it as a disease that occurs in children. Although exceedi...
When should I refer to a melanoma clinic?
10 Dec 2019
Contributed by Lukas
In the evolving treatment landscape of melanoma, it is important for GPs and Dermatologists to be confident in managing or knowing when to refer their...
What GPs need to know about melanoma patients on systemic therapies
02 Oct 2019
Contributed by Lukas
In the last decade, the treatment landscape for melanoma has been transformative for patients with advanced disease. Although managed primarily by med...
Food, Mood and Move in Melanoma
27 May 2019
Contributed by Lukas
Thanks to advancements in therapy, we are now seeing large numbers of patients surviving advanced melanoma, and with that comes well-being and psychol...
Management of Brain Metastases in Melanoma
22 Mar 2019
Contributed by Lukas
The management of melanoma patients with brain metastases has changed rapidly in the last five years, and patients now have much-improved survival rat...